Bronwyn Joubert

Bronwyn Joubert is a Senior Scientist at Revvity since May 2023, with a significant tenure at Horizon Discovery beginning in October 2016, where roles included Senior Scientist in Immunology R&D and Therapeutic Applications of Base Editing R&D. Responsibilities encompassed the development of CRISPR-Cas9 knockout screening in primary human T lymphocytes and proof of concept data for base editing. Prior experience includes a lecturer and scientist position at the University of KwaZulu-Natal from 2007 to June 2016, overseeing academic and research activities and supervising postgraduate students. Educational qualifications include a PhD in Medical Microbiology and various diplomas from the University of KwaZulu-Natal and Marshall Skills Academy.